Juan Andres - Sep 17, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Technical Operations and Quality Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Sep 17, 2021
Transactions value $
-$4,157,200
Form type
4
Date filed
9/21/2021, 04:17 PM
Previous filing
Sep 17, 2021
Next filing
Sep 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $61.1K +5K $12.21* 5K Sep 17, 2021 Direct F1
transaction MRNA Common Stock Sale -$2.19M -5K -100% $438.24 0 Sep 17, 2021 Direct F1
transaction MRNA Common Stock Options Exercise $61.1K +5K $12.21* 5K Sep 20, 2021 Direct F1
transaction MRNA Common Stock Sale -$2.09M -5K -100% $417.62 0 Sep 20, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -5K -1.92% $0.00 255K Sep 17, 2021 Common Stock 5K $12.21 Direct F1, F2
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -5K -1.96% $0.00 250K Sep 20, 2021 Common Stock 5K $12.21 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020, and amended on May 12, 2021.
F2 This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer